Alvotech and LOTTE Biologics Sign US Manufacturing Deal
Alvotech and LOTTE Biologics have signed a US manufacturing deal for multiple biosimilars, expanding global manufacturing capacity at LOTTE’s Syracuse facility.
Lisa Graver | 07/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy